Dataset
Indapamide; LC-ESI-Q; MS; POS; 60 V
Chemical Information
| InChI | InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23) |
|---|---|
| SMILES | O=C(NN(C(C)2)c(c3)c(ccc3)C2)c(c1)cc(c(Cl)c1)S(N)(=O)=O |
| InChI Key | NDDAHWYSQHTHNT-UHFFFAOYSA-N |
| Molecular Formula | C16H16ClN3O3S |
| Exact Mass | 365.060 g/mol |
Data and Resources
Metadata Information
| Field | Value |
|---|---|
| DOI | |
| License URL | https://creativecommons.org/licenses/by-nc/4.0 |
| Source | https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Waters-WA000789 |
| Version | |
| Author | |
| Maintainer | |
| Language | |
| MetadataPublished | 2016-01-19 |
| Related Molecule |
|
| Field | Value |
|---|---|
| Measurement Technique | liquid chromatography-mass spectrometry |
| Measurement Variables |
| Data-Source Molecule ID | Data-Source |
|---|---|
| PD002293 | ProbesDrugs |
| 5893 | ChEBI |
| LSM-1936 | LINCS |
| 14828553 | PubChem: Thomson Pharma |
| Indapamide(Lozol) | Selleck |
| PA449975 | PharmGKB |
| 26807-65-8 | ACToR |
| 539574 | eMolecules |
| HMDB0014946 | Human Metabolome Database |
| indapamide | DailyMed |
| CB2420420 | ChemicalBook |
| 6336 | Brenda |
| MCULE-1549472772 | Mcule |
| 3702 | PubChem |
| SCHEMBL41303 | SureChEMBL |
| DB00808 | DrugBank |
| CHEMBL406 | ChEMBL |
| SAM002564214 | NIH Clinical Collection |
| J10.425F | Nikkaji |
| LOZOL | clinicaltrials |
| HY-B0259 | MedChemExpress |
| F089I0511L | FDA SRS |
| 7203 | Guide to Pharmacology |
| DTXSID7044633 | EPA CompTox Dashboard |
| SE-1520 | clinicaltrials |
| INDAPAMIDE | DailyMed |
| 25901 | BindingDB |
| INDAPAMIDE | rxnorm |
| S-1520 | clinicaltrials |
| 1433 | DrugCentral |
| NATRILIX | clinicaltrials |
| INDAPAMIDE | clinicaltrials |
| The data in this table is sourced from UniChem at EBI. | |